Back to 
Schonfeld Strategic Advisors LLC
Schonfeld Strategic Advisors LLC
LGND
Showing 0 of 6 quarters
Position history for Schonfeld Strategic Advisors LLC's holdings in Ligand Pharmaceuticals Incorporated
No. Schonfeld Strategic Advisors exited its LGND (Ligand Pharmaceuticals) position in Q2 2024. Its Q1 2024 13F listed 9,121 shares worth $666,745. Schonfeld Strategic Advisors first reported LGND in Q2 2019 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.